{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T18:21:40Z","timestamp":1782152500757,"version":"3.54.5"},"reference-count":40,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2012,1,12]],"date-time":"2012-01-12T00:00:00Z","timestamp":1326326400000},"content-version":"vor","delay-in-days":11,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.6061\/clinics\/2012(01)10","type":"journal-article","created":{"date-parts":[[2012,1,9]],"date-time":"2012-01-09T13:02:53Z","timestamp":1326114173000},"page":"61-67","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Reduced occurrence of programmed cell death and gliosis in the retinas of juvenile rabbits after short-term treatment with intravitreous bevacizumab"],"prefix":"10.1016","volume":"67","author":[{"given":"Maria Alice","family":"Fusco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9 Lu\u00eds Freire","family":"Portes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvana","family":"Allodi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haroldo Vieira","family":"de Moraes Junior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e1rio Luiz Ribeiro","family":"Monteiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N\u00e1dia Campos","family":"de Oliveira Miguel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.6061\/clinics\/2012(01)10_bib1","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.neuro.2008.06.006","article-title":"Absence of intravitreal bevacizumab-induced neuronal toxicity in the retina","volume":"29","author":"Kim","year":"2008","journal-title":"Neurotoxicology"},{"key":"10.6061\/clinics\/2012(01)10_bib2","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.survophthal.2009.02.004","article-title":"Bevacizumab (Avastin) for the treatment of ocular disease","volume":"54","author":"Gunther","year":"2009","journal-title":"Surv Ophthalmol"},{"key":"10.6061\/clinics\/2012(01)10_bib3","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ophtha.2005.02.007","article-title":"Systemic bevacizumab (Avastin) therapy for neovascular age-related macular degeneration twelve-week results of an uncontrolled open-label clinical study","volume":"112","author":"Michels","year":"2005","journal-title":"Ophthalmology"},{"key":"10.6061\/clinics\/2012(01)10_bib4","doi-asserted-by":"crossref","first-page":"20","DOI":"10.4103\/0301-4738.36474","article-title":"Bevacizumab: off-label use in ophthalmology","volume":"55","author":"Grisanti","year":"2007","journal-title":"Indian J Ophthalmol"},{"key":"10.6061\/clinics\/2012(01)10_bib5","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1387\/ijdb.041895ms","article-title":"Development and pathology of the hyaloid, choroidal and retinal vasculature","volume":"48","author":"Saint-Geniez","year":"2004","journal-title":"Int J Dev Biol"},{"key":"10.6061\/clinics\/2012(01)10_bib6","doi-asserted-by":"crossref","first-page":"8","DOI":"10.2353\/ajpath.2007.070385","article-title":"Vascular endothelial cell growth factor-a: not just for endothelial cells anymore","volume":"171","author":"D'Amore","year":"2007","journal-title":"Am J Pathol"},{"key":"10.6061\/clinics\/2012(01)10_bib7","doi-asserted-by":"crossref","first-page":"67","DOI":"10.2353\/ajpath.2007.061237","article-title":"Vascular endothelial growth factor-A is a survival factor for retinal neurons and a critical neuroprotectant during the adaptive response to ischemic injury","volume":"171","author":"Nishijima","year":"2007","journal-title":"Am J Pathol"},{"key":"10.6061\/clinics\/2012(01)10_bib8","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.earlhumdev.2007.11.007","article-title":"Treatment of retinopathy of prematurity","volume":"84","author":"Clark","year":"2008","journal-title":"Early Hum Dev"},{"key":"10.6061\/clinics\/2012(01)10_bib9","doi-asserted-by":"crossref","first-page":"e3554","DOI":"10.1371\/journal.pone.0003554","article-title":"Endogenous VEGF is required for visual function: evidence for a survival role on muller cells and photoreceptors","volume":"3","author":"Saint-Geniez","year":"2008","journal-title":"PLoS One"},{"key":"10.6061\/clinics\/2012(01)10_bib10","first-page":"9","article-title":"Effects of anti-VEGF agents on rat retinal Muller glial cells","volume":"16","author":"Guo","year":"2010","journal-title":"Mol Vis"},{"key":"10.6061\/clinics\/2012(01)10_bib11","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1167\/iovs.06-0828","article-title":"Preclinical safety evaluation of intravitreal injection of full-length humanized vascular endothelial growth factor antibody in rabbit eyes","volume":"48","author":"Inan","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.6061\/clinics\/2012(01)10_bib12","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.ajo.2007.03.007","article-title":"Ultrastructural findings in the primate eye after intravitreal injection of bevacizumab","volume":"143","author":"Peters","year":"2007","journal-title":"Am J Ophthalmol"},{"key":"10.6061\/clinics\/2012(01)10_bib13","unstructured":"Akkoyun I, Karabay G, Haberal N, Dagdeviren A, Yilmaz G, Oto S, et al. Structural consequences after intravitreal bevacizumab injection without increasing apoptotic cell death in a retinopathy of prematurity mouse model. Acta Ophthalmol"},{"key":"10.6061\/clinics\/2012(01)10_bib14","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.ajo.2006.03.058","article-title":"Absence of histologic retinal toxicity of intravitreal bevacizumab in a rabbit model","volume":"142","author":"Bakri","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"10.6061\/clinics\/2012(01)10_bib15","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/01.iae.0000222547.35820.52","article-title":"Evaluation of in vitro effects of bevacizumab (Avastin) on retinal pigment epithelial, neurosensory retinal, and microvascular endothelial cells","volume":"26","author":"Luthra","year":"2006","journal-title":"Retina"},{"key":"10.6061\/clinics\/2012(01)10_bib16","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/01.iae.0000230717.85319.f5","article-title":"Safety of intravitreal injection of bevacizumab in rabbit eyes","volume":"26","author":"Feiner","year":"2006","journal-title":"Retina"},{"key":"10.6061\/clinics\/2012(01)10_bib17","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/00006982-200603000-00001","article-title":"Testing intravitreal toxicity of bevacizumab (Avastin)","volume":"26","author":"Manzano","year":"2006","journal-title":"Retina"},{"key":"10.6061\/clinics\/2012(01)10_bib18","doi-asserted-by":"crossref","DOI":"10.1097\/IAE.0b013e31821a88e2","article-title":"Safety of Intravitreal Bevacizumab in the Developing Rabbit Retina","author":"Zayit-Soudry","year":"2011","journal-title":"Retina"},{"key":"10.6061\/clinics\/2012(01)10_bib19","first-page":"97","article-title":"Development of the rabbit retina. I. Size of eye and retina, and postnatal cell proliferation","volume":"183","author":"Reichenbach","year":"1991","journal-title":"Anat Embryol (Berl)"},{"key":"10.6061\/clinics\/2012(01)10_bib20","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/00006982-200603000-00002","article-title":"Electrophysiologic and retinal penetration studies following intravitreal injection of bevacizumab (Avastin)","volume":"26","author":"Shahar","year":"2006","journal-title":"Retina"},{"key":"10.6061\/clinics\/2012(01)10_bib21","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1167\/iovs.07-0731","article-title":"The effects of intravitreous bevacizumab on retinal neovascular membrane and normal capillaries in rabbits","volume":"48","author":"Ameri","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.6061\/clinics\/2012(01)10_bib22","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s00417-009-1136-0","article-title":"Different properties of VEGF-antagonists: Bevacizumab but not Ranibizumab accumulates in RPE cells","volume":"247","author":"Klettner","year":"2009","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.6061\/clinics\/2012(01)10_bib23","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1755-3768.2008.01410.x","article-title":"In vitro evaluation of bevacizumab toxicity on a retinal ganglion cell line","volume":"87","author":"Sharma","year":"2009","journal-title":"Acta Ophthalmol"},{"key":"10.6061\/clinics\/2012(01)10_bib24","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/cdd.2008.40","article-title":"The autophagic machinery is necessary for removal of cell corpses from the developing retinal neuroepithelium","volume":"15","author":"Mellen","year":"2008","journal-title":"Cell Death Differ"},{"key":"10.6061\/clinics\/2012(01)10_bib25","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1387\/ijdb.072446av","article-title":"Early neural cell death: numbers and cues from the developing neuroretina","volume":"53","author":"Valenciano","year":"2009","journal-title":"Int J Dev Biol"},{"key":"10.6061\/clinics\/2012(01)10_bib26","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/IAE.0b013e318177f934","article-title":"Intravitreal injection of bevacizumab (avastin) for treatment of stage 3 retinopathy of prematurity in zone I or posterior zone II","volume":"28","author":"Mintz-Hittner","year":"2008","journal-title":"Retina"},{"key":"10.6061\/clinics\/2012(01)10_bib27","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1167\/iovs.07-1225","article-title":"Subretinal bevacizumab detection after intravitreous injection in rabbits","volume":"49","author":"Dib","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.6061\/clinics\/2012(01)10_bib28","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1167\/iovs.08-3148","article-title":"Pharmacokinetics of bevacizumab after topical, subconjunctival, and intravitreal administration in rabbits","volume":"50","author":"Nomoto","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.6061\/clinics\/2012(01)10_bib29","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S1350-9462(98)00020-2","article-title":"Apoptosis in developing retinal tissue","volume":"18","author":"Linden","year":"1999","journal-title":"Prog Retin Eye Res"},{"key":"10.6061\/clinics\/2012(01)10_bib30","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/cr.2007.78","article-title":"Physiological functions of Atg6\/Beclin 1: a unique autophagy-related protein","volume":"17","author":"Cao","year":"2007","journal-title":"Cell Res"},{"key":"10.6061\/clinics\/2012(01)10_bib31","doi-asserted-by":"crossref","first-page":"41","DOI":"10.4161\/auto.4294","article-title":"Apoptosis and autophagy in photoreceptors exposed to oxidative stress","volume":"3","author":"Kunchithapautham","year":"2007","journal-title":"Autophagy"},{"key":"10.6061\/clinics\/2012(01)10_bib32","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1042\/BST0360813","article-title":"How autophagy is related to programmed cell death during the development of the nervous system","volume":"36","author":"Boya","year":"2008","journal-title":"Biochem Soc Trans"},{"key":"10.6061\/clinics\/2012(01)10_bib33","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s00418-008-0406-y","article-title":"Autophagy-physiology and pathophysiology","volume":"129","author":"Uchiyama","year":"2008","journal-title":"Histochem Cell Biol"},{"key":"10.6061\/clinics\/2012(01)10_bib34","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.preteyeres.2006.05.003","article-title":"Muller cells in the healthy and diseased retina","volume":"25","author":"Bringmann","year":"2006","journal-title":"Prog Retin Eye Res"},{"key":"10.6061\/clinics\/2012(01)10_bib35","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.neuint.2008.05.002","article-title":"Expression of functional dopaminergic phenotype in purified cultured Muller cells from vertebrate retina","volume":"53","author":"Kubrusly","year":"2008","journal-title":"Neurochem Int"},{"key":"10.6061\/clinics\/2012(01)10_bib36","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.neuint.2008.10.014","article-title":"Role of retinal glial cells in neurotransmitter uptake and metabolism","volume":"54","author":"Bringmann","year":"2009","journal-title":"Neurochem Int"},{"key":"10.6061\/clinics\/2012(01)10_bib37","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/path.1645","article-title":"Astrocyte intermediate filaments in CNS pathologies and regeneration","volume":"204","author":"Pekny","year":"2004","journal-title":"J Pathol"},{"key":"10.6061\/clinics\/2012(01)10_bib38","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1172\/JCI31030","article-title":"Fibrosis and diseases of the eye","volume":"117","author":"Friedlander","year":"2007","journal-title":"J Clin Invest"},{"key":"10.6061\/clinics\/2012(01)10_bib39","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/IIO.0b013e318169544f","article-title":"Retinopathy of prematurity update","volume":"48","author":"Rubaltelli","year":"2008","journal-title":"Int Ophthalmol Clin"},{"key":"10.6061\/clinics\/2012(01)10_bib40","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s00417-009-1249-5","article-title":"A systematic review on the effect of bevacizumab in exudative age-related macular degeneration","volume":"248","author":"Schmucker","year":"2010","journal-title":"Graefes Arch Clin Exp Ophthalmol"}],"container-title":["Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1807593222022840?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1807593222022840?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/clinics.org.br\/uploads\/artigos\/cln-67-01\/cln-67-01-61.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T07:11:21Z","timestamp":1761721881000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1807593222022840"},"secondary":[{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_abstract&pid=S1807-59322012000100010&lng=en&nrm=iso","label":"SCIELO"},{"URL":"http:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3248603\/?report=classic","label":"PMC"}]},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["S1807593222022840"],"URL":"https:\/\/doi.org\/10.6061\/clinics\/2012(01)10","relation":{},"ISSN":["1807-5932"],"issn-type":[{"value":"1807-5932","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reduced occurrence of programmed cell death and gliosis in the retinas of juvenile rabbits after short-term treatment with intravitreous bevacizumab","name":"articletitle","label":"Article Title"},{"value":"Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.6061\/clinics\/2012(01)10","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 CLINICS. Published by Elsevier Spain","name":"copyright","label":"Copyright"}]}}